Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Organic compounds
(total 903 related compounds in database, current show from 331 to 340)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
Compound 25
(internal name in literature)		 Depiction based on curated SMILES N S O OH OH O N F F N H Chlamydia TTSS (Type III secretion system) Preclinical (in vitro) Zigangirova NA, et al. 2012. Acta Naturae
Compound 27
(internal name in literature)		 Depiction based on curated SMILES O S F F F CH 3 HN O N N OH O Chlamydia TTSS (Type III secretion system) Preclinical (in vitro) Zigangirova NA, et al. 2012. Acta Naturae
(2R)-2-[[3-(1-benzofuran-2-yl)phenyl]sulfonylamino]-N-hydroxy-4-methylpentanamide Depiction based on curated SMILES OH HN O O H 3 C O O S N H H CH 3 Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
(2R,3R)-2-[[3-(1-benzofuran-2-yl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide Depiction based on curated SMILES HO N H O O CH 3 O O S HN H H 3 C H Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
(2R,3R)-2-[[3-(2-chlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide Depiction based on curated SMILES OH N H O Cl CH 3 O O S N H H H 3 C Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
(2S)-2-[[3-(1-benzofuran-2-yl)phenyl]sulfonylamino]-N-hydroxyhexanamide Depiction based on curated SMILES HO N H O O CH 3 O O S HN H Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
(2S,3S)-2-[[3-(1-benzofuran-2-yl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide Depiction based on curated SMILES OH N H O O H 3 C O O S N H H 3 C Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
(2S,3S)-2-[[3-(2,4-dichlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide Depiction based on curated SMILES OH N H O Cl Cl H 3 C O O S HN CH 3 Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
(2S,3S)-2-[[3-(2,5-dichlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide Depiction based on curated SMILES OH N H O Cl Cl H 3 C O O S HN CH 3 Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
(2S,3S)-2-[[3-(2,6-dichlorophenyl)phenyl]sulfonylamino]-N-hydroxy-3-methylpentanamide Depiction based on curated SMILES OH N H O Cl Cl H 3 C O O S HN CH 3 Clostridium BoNT (Botulinum neurotoxin) Preclinical (in vitro) Thompson JC, et al. 2020. Bioorg Med Chem
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page 1  ...  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  ...  91



Back to top
2004-2025 NIPB, CAMS&PUMC